REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

E.S.E. Bellosalud (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: E.S.E. Bellosalud Profile Updated: September 03, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

E.S.E. Bellosalud is a company based in Colombia, with its head office in Bello. The company operates in the Ambulatory Health Care Services sector. The company was established on December 17, 2014. In its most recent financial highlights, the company reported a net sales revenue increase of 16.81% in 2025. Its total assets grew by 14.78% over the same period. The net profit margin of E.S.E. Bellosalud decreased by 14.33% in 2025.

Headquarters
Carrera 42 20E91
Bello; Antioquia; Postal Code: 051053

Contact Details: Purchase the E.S.E. Bellosalud report to view the information.

Website: http://www.esebellosalud.gov.co

Basic Information
Registered Capital:
Purchase the E.S.E. Bellosalud report to view the information.
Financial Auditors:
Purchase the E.S.E. Bellosalud report to view the information.
Incorporation Date:
December 17, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Treasurer
Purchase this report to view the information.
Head of Internal Control
Company Performance
Financial values in the chart are available after E.S.E. Bellosalud report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
16.81%▲
Total Operating Revenue
16.2%▲
Operating Profit
-53.21%▼
EBITDA
-40.61%▼
Net Profit/Loss for the Period
-76.4%▼
Total Assets
14.78%▲
Total Equity
8.85%▲
Operating Profit Margin
-11.69%▼
Net Profit Margin
-14.33%▼
Return on Equity (ROE)
-27.34%▼
Quick Ratio
0.1%▲
Cash Ratio
0.41%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo